Evofem Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-146.7M | $-149.6M | $2.9M | $8.9M |
| FY2022 | $-70.4M | $-70.8M | $341.0K | $3.3M |
| FY2023 | $-9.0M | $-9.0M | $4.0K | $1.2M |
| FY2024 | $-3.9M | $-3.9M | $14.0K | $847.0K |
| FY2025 | $-2.0M | $-2.0M | $5.0K | $166.0K |